Acta Parasitologica

, Volume 64, Issue 4, pp 916–922 | Cite as

Clinical and Pathological Aspects of Canine Cutaneous Leishmaniasis: A Meta-analysis

  • Caroline Sobotyk OliveiraEmail author
  • Fabiana Raquel Ratzlaff
  • Luciana Pötter
  • Pedro Roosevelt Torres Romão
  • Sônia de Avila Botton
  • Fernanda Silveira Flores Vogel
  • Luis Antonio Sangioni
Short Communication



In the present study, we described the most prevalent clinical symptoms, the most affected organs, and the macro and microscopic lesions associated with cutaneous leishmaniasis.


Two independent researchers performed an extensive systematic review of the literature in four stages (identification, screening, eligibility, and inclusion) to identify studies published between January 2002 and November 2018 from the following electronic databases: Web of Science, PubMed, SciELO, Science Direct, and Google Scholar. Meta-analysis was conducted in “Metaprop” package of R 3.4.2 software.


The electronic search yielded 3896 results, out of which 155 were further analyzed based on the full-text. Data extracted from 16 articles were included in the meta-analysis, representing a total of 430 leishmaniasis cases. Only 43% of all animals were identified to exhibit the clinical and cutaneous changes characteristic of leishmaniasis based on the observation that skin lesions were the most prevalent clinical sign and were present in 86% of all cases. Other less prevalent symptoms included weight loss, cachexia, apathy and lymph node enlargement. Histopathological analysis showed that the skin was the most affected organ, affecting 64% of cases, followed by lymph nodes (12%), spleen (8%) and liver (7%).


Therefore, our current findings suggest that cutaneous leishmaniasis could lead to visceral disease. Notably, our findings indicated no clinical manifestation patterns in cutaneous leishmaniasis, since the same host species may present different clinical conditions.


Leishmania Dog Clinical condition Histopathology Meta-analysis 



  1. 1.
    Alexander B, Agudelo LA, Navarro F, Ruiz F, Molina J, Aguilera G, Quiñones ML (2001) Phlebotomine sandflies and leishmaniasis risks in Colombian coffee plantations under two systems of cultivation. Med Vet Entomol 15:364–373. CrossRefGoogle Scholar
  2. 2.
    Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Boer M, The WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7(5):e35671. CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Auwera GV, Dujardin JC (2015) Species typing in dermal leishmaniasis. Clin Microbiol Rev 28(2):265–294. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bahrami F, Harandi AM, Rafati S (2018) Biomarkers of cutaneous leishmaniasis. Front Cell Infect Microbiol 8:1–8. CrossRefGoogle Scholar
  5. 5.
    Calzada JE, Saldaña A, González K, Rigg C, Pineda V, Santamaría AM, Rodríguez I, Gottdenker NL, Laurenti MD, Chaves LF (2015) Cutaneous leishmaniasis in dogs: is high seroprevalence indicative of a reservoir role? Parasitology 142(9):1202–1214. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Cardoso FO, Souza CSF, Mendes VG, Abreu-Silva AL, Costa SCG, Calabrese KS (2010) Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice. J Infect Dis 201(12):1933–1940. CrossRefGoogle Scholar
  7. 7.
    Chaves LF, Cohen JM, Pascual M, Wilson ML (2008) Social exclusion modifies climate and deforestation impacts on a vector borne disease. PLoS Negl Trop Dis 2:e176. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Coura JR, Castro SLA (2002) Critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97(1):3–24. CrossRefGoogle Scholar
  9. 9.
    Coura-Vital W, Reis AB, Fausto MA, Leal GG, Marques MJ, Veloso VM, Carneiro M (2013) Risk factors for seroconversion by Leishmania infantum in a cohort of dogs from an endemic area of Brazil. PLoS One 8:e71833. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Day MJ (2011) The immunopathology of canine vector-borne diseases. Parasites Vectors 4(48):1–13. CrossRefGoogle Scholar
  11. 11.
    Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27(5):305–318. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Gavgani ASM, Hodjati MH, Mohite H, Davies CR (2002) Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360(9330):374–379. CrossRefPubMedGoogle Scholar
  13. 13.
    Goto H, Lindoso JAL (2012) Cutaneous and mucocutaneous leishmaniasis. Infect Dis Clin N Am 26(2):293–307. CrossRefGoogle Scholar
  14. 14.
    Grimaldi G Jr, Tesh RB (1993) Leishmaniases of the new World: current concepts and implications for future research. Clin Microbiol Rev 6(3):230–250. CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA (2015) Cutaneous and mucocutaneous leishmaniasis: clinical perspectives. J Am Acad Dermatol 73(6):897–908. CrossRefPubMedGoogle Scholar
  16. 16.
    Hashiguchi Y, Eduardo A, Gomez L, Cáceres AG, Velez LN, Villegas NV, Hashiguchi K, Mimori T, Uezato H, Kato H (2018) Andean cutaneous leishmaniasis (Andean-CL, uta) in Peru and Ecuador: the vector Lutzomyia sand flies and reservoir mammals. Acta Trop 178:264–275. CrossRefPubMedGoogle Scholar
  17. 17.
    Kevric I, Cappel MA, Keeling JH (2015) New world and old world leishmania infections: a practical review. Dermatol Clin 33(3):579–593. CrossRefPubMedGoogle Scholar
  18. 18.
    Lage RS, Oliveira GC, Busek SU, Guerra LL, Giunchetti RC, Corrêa-Oliveira R, Reis AB (2007) Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi. Vet Immunol Immunopathol 115(1–2):135–145. CrossRefPubMedGoogle Scholar
  19. 19.
    Marco JD, Padilla AM, Diosque P, Fernández MM, Malchiodi EL, Basombrío MA (2001) Force of infection and evolution of lesions of canine tegumentary leishmaniasis in Northwestern Argentina. Mem Inst Oswaldo Cruz 96(5):649–652. CrossRefPubMedGoogle Scholar
  20. 20.
    Marzochi MCA, Marzochi KBF (1994) Tegumentary and visceral leishmaniases in Brazil—emerging anthropozoonosis and possibilities for their control. Cad Saúde Públ 10(2):359–375. CrossRefGoogle Scholar
  21. 21.
    Mitropoulos P, Konidas P, Durkin-Konidas M (2010) New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol 63(2):309–322. CrossRefPubMedGoogle Scholar
  22. 22.
    Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Oliveira BC, Mendes APO, Castro MCAB, Hernandes VP (2016) American tegumentary leishmaniasis and flow cytometry: a review. J Med Microb Diagn 5(1):1–5. CrossRefGoogle Scholar
  24. 24.
    Reis AB, Giunchetti RC, Carrillo E, Martins-Filho OA, Moreno J (2010) Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis. Trends Parasitol 26(7):341–349. CrossRefPubMedGoogle Scholar
  25. 25.
    Ribeiro RR, Michalick MSM, Silva ME, Santos CCP, Frézard FJG, Silva SM (2018) Canine leishmaniasis: an overview of the current status and strategies for control. Biomed Res Int 2018:1–12. CrossRefGoogle Scholar
  26. 26.
    Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol 16:581–592. CrossRefPubMedGoogle Scholar
  27. 27.
    Tirelli F, Vernal S, Roselino AM (2017) Final diagnosis of 86 cases included in differential diagnosis of American tegumentary leishmaniasis in a Brazilian sample: a retrospective cross-sectional study. Ann Bras Dermatol 92(5):642–648. CrossRefGoogle Scholar
  28. 28.
    Torrentera FA, Lambot MA, Laman JD, Meurs MV, Kiss R, Noël JC, Carlier Y (2002) Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana. Am J Trop Med Hyg 66(3):273–279. CrossRefGoogle Scholar
  29. 29.
    Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R (2017) Leishmaniasis: a review. F1000Res 6:1–15. CrossRefGoogle Scholar
  30. 30.
    Travi BL, Cordeiro-Da-Silva A, Dantas-Torres F, Miró G (2018) Canine visceral leishmaniasis: diagnosis and management of the reservoir living among us. PLoS Negl Trop Dis 12(1):e0006082. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    WHO—World Health Organization (2010) Control of leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. WHO technical report series, Geneva, no. 949Google Scholar

Copyright information

© Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2019

Authors and Affiliations

  • Caroline Sobotyk Oliveira
    • 1
    Email author
  • Fabiana Raquel Ratzlaff
    • 1
  • Luciana Pötter
    • 2
  • Pedro Roosevelt Torres Romão
    • 3
  • Sônia de Avila Botton
    • 1
  • Fernanda Silveira Flores Vogel
    • 1
  • Luis Antonio Sangioni
    • 1
  1. 1.Programa de Pós Graduação em Medicina Veterinária, Departamento de Medicina Veterinária PreventivaUniversidade Federal de Santa (UFSM)Santa MariaBrazil
  2. 2.Programa de Pós Graduação em Zootecnia, Departamento de ZootecniaUniversidade Federal de Santa (UFSM)Santa MariaBrazil
  3. 3.Laboratório de Imunologia, Departamento de Ciências Básicas da SaúdeUniversidade Federal de Ciências da Saúde de Porto AlegrePorto AlegreBrazil

Personalised recommendations